Épidémie de myopie en pédiatrie : prise en charge, prévention et traitement [Outbreak of myopia in pediatrics : management, prevention and treatment]

Fiche du document

Date

20 décembre 2023

Types de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.855.2407

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/38117111

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_E6F787905A168

Licences

info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2025-06-20 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/


Résumé 0

The worldwide incidence and prevalence of myopia has increased. The age of onset of this refractive disorder has inversely decreased. In addition to genetic and familial factors, environmental factors related to a sedentary lifestyle and activities in highly solicited near vision seem to have an impact on the development of axial myopia, that is an early and non-reversible elongation of the eyeball. Prevention of the development of myopia in pediatrics through simple daily measures plays therefore a fundamental role. In addition, pharmacological treatments, and specific optical treatments for controlling myopia have shown encouraging results in reducing the risk of long-term complications of progressive myopia, that is increased risk of developing cataract, glaucoma, retinal detachment, or maculopathy.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en